|
breast explorationn
Fine Needle Aspiration
Fine needle aspiration is probably the most expedient method. It is generally performed in the office, and diagnostic accuracy approaches 100%. The false negative rate is 2-10%. However, a negative result does not exclude cancer.
Tru Cut Needle Biopsy
Tru Cut Needle Biopsy is also done in the office, usually requires local anesthesia and takes a larger sample of tissue. This needle is more often used for a large palpable mass.
Incisional Biopsy
Incisional biopsy involves removing only a sample of tissue surgically from a very large mass for diagnostic purposes. This is performed in an operating room.
Excisional Biopsy
Excisional biopsy is the term used to describe removal of the entire mass. This type of biopsy is performed in an operating room under local or general anesthesia.
The technic of exploration are evoluating year after year better and more sofisticated the first step of a breast exploration is the self paplaption, which each women should do starting from 18 years old
the mammography as the old fashion detection especially starting from the 40, and the last new techic as indtroducing a canera [laparoscope] intra the duct for biopsy and direct visu
Screening
1. Breast examination
Most breast cancers present as palpable mass. 10-15% of cancers detectable only by clinical exam. Best to examine shortly after menses.
2. Mammography
i. Recommended frequency (ACS)
Baseline exam between 35-40y. Every other year between age 40-50. Annually after age 50. Only 25-35% of women are currently screened following the guidelines. Ultrasound more effective for women < 35y.
ii. Efficacy
42% of breast cancers detectable only by mammography. Regularly screened women have 30-40% less breast cancer mortality, and 25% fewer cases are advanced stage at diagnosis. False negative rate 10-15%.
iii. Technique
Breasts compressed. Radiation dose 0.1cGy. Cancers typically have irregular contour or calcifications of variable size or linear arrangement
new technics are being put in the market as intraductal videoscopy of the breast to explore and biopsy and evaluate a cancer which is no see on the normal tech
Breast Self-Examination (BSE) 
 |
 |
|
|
In front of a mirror :
1. Stand directly in front of mirror.
2. Place your hands at your side.
3. Check your breasts for any changes in size, shape, color, dimpling, or scaling of the skin.
4. Check your breasts again. This time place hands on hips, pressing shoulders and elbows forward to flex chest muscles, then raising hands and clasping gently behind head.
|
 |
 |
 |
In the shower :
1. Raise right arm.
2. With the flat part of the fingers of your right hand, carefully examine your right breast.
3. Using a circular pattern, start from the outer top, pressing firmly to feel your breast tissue under- neath.
4. After a full circle, move one inch inward and circle again.
5. Perform circular patterns until reaching the nipple.
6. Check area above the breast and armpit area for lumps or hard knots.
7. Repeat same procedure with left breast.
|
|
|
|
 |
Lying down :
1. Prepare a pillow.
2. Put pillow under your right shoulder.
3. Raise your right hand above your head.
4. Examine your entire breast in the circular motion pattern describe above (in the shower).
5. Repeat with your left breast.
6. Gently squeeze each nipple to check for discharge.
|
Breast Self-Exam should be done at the same time once a month. The best time would be two or three days after the end of your period. Report any changes or abnormalities to your physician.
ABNORMALITIES FOUND ON  MAMMOGRAPHY
Abnormalities seen on mammography may be either a mass which is too deep in the breast to feel, or an area of clustered microcalcifications.
Masses
Solid nodules in the breast. Signs of malignancy are related to the countour or margins of the mass.
Well circumscribed masses with smooth margins usually represent benign lesions such as fibroadenomas or lymph nodes.
Irregularly shaped masses with spiculated margins may be an indicator of cancer.
Microcalcifications
Calcifications are tiny specks of calcium seen on mammography. Many of these are associated with a benign process and have a typical appearance.
Calcifications that are widely scattered, of uniform size and well defined usually represent a benign condition.
Irregular calcifications that are heterogeneous in size, that are clustered together may indicate the presence of malignancy. A small mass may or may not be associated with the calcification.
What To Do
Most abnormal findings on mammography do not have unequivocal signs of either a benign or malignant condition. Therefore, a biopsy may be recommended by either the radiologist or surgeon to obtain tissue for definitive diagnosis.
The following biopsy methods can be used:.
Needle localization and excisional biopsy
A procedure in which the radiologist places a thin wire into the breast and marks the spot with the hook of the wire so that the surgeon may be able to find the abnormal area in the breast to remove. The wire is inserted about an hour before the procedure and the biopsy is performed in an operating room. This is done on an outpatient basis.
Stereotactic biopsy
A newer technique for biopsying nonpalpable breast abnormalities. It is a nonsurgical biopsy. A computerized mammography machine localizes the abnormality in three dimensions, and then a biopsy needle is guided by the computer to take core biopsies of the mass or area of calcifications. It is a wonderful alternative to an open biopsy, but it is not appropriate for all abnormal findings on mammography.
Biopsy  Results
There are several types of benign breast disorders. Fibrocystic breasts affect nearly 50% of American women. Fibrocystic breasts include cysts, sclerosing adenosis and hyperplasia.
Malignant or cancerous biopsies generally fall into one of the two major categories of breast cancer: Invasive or Noninvasive. A number of treatments are available.
Detection: Screening mammography is the best method of detecting early breast cancer as illustrated on the right figures.
Currently there are two types of imaging technologies which allow the physician to access mammographically detected breast tumors with a needle:
A) stereotaxic needle biopsy and
B) ultrasound guided needle biopsy.
Stereotaxic needle biopsy is a method by which small pieces of tissue may be removed from the breast, under x-ray guidance and local anesthesia, through a skin puncture or a small incision. Of the many suspicious looking shadows found on routine mammogram, less than one-third are actually cancerous
Stereotactic needle biopsy is a method by which small pieces of tissue may be removed from the breast, under x-ray guidance, through a skin puncture or a small incision and without surgery. Of the many suspicious-looking shadows found on routine mammograms, less than one third are actually cancerous. Stereotactic needle biopsy allows accurate diagnosis of the majority of these lesions without open biopsy.
The stereotactic needle biopsy is an outpatient procedure and may be scheduled through a physician's office. During the procedure, the patient lies on a special examination table while x-rays and a computer are used to identify the exact location of the lesion
 The skin of the breast is then anesthetized and the biopsy needle inserted. Correct placement is confirmed by x-ray. There are several types of needles and devices for sampling. One type has a notch in it to remove tissue samples (cores) from the area of concern. About five or six cores are taken to ensure adequate sampling. These are then taken to the pathologist for testing to see if the tissue is cancerous or not. Other tests may also be done on the samples should they prove positive for cancer.
 Results are usually available two to three days post-biopsy. If the results are adequate and show no evidence of cancer a follow-up mammogram in 6-12 months is recommended. Should the pathology report reveal malignant or suspicious, or in less than 5%, inadequate, the patient is scheduled for surgical removal of the lesion (open biopsy). This is usually done under local anesthesia, with or without intravenous sedation.
 This is a method that allows many women to avoid unnecessary surgery. Approximately 3/4 of all breast biopsies currently performed in the U.S. for abnormal mammograms turn out to be benign. Stereotactic needle biopsy is a method by which women at low risk for cancer may safely have a correct diagnosis without surgery.
 The likelihood of a cancer to be missed by stereotactic needle biopsy is approximately 2%, the same rate as open biopsy.
 During the past decade, high resolution ultrasound has emerged as an alternative to x-ray to visualize breast tumors smaller than 5mm (1/5in) for needle biopsy.
 Many physicians nowadays use ultrasound machines to guide the needle to the tumor in the breast, again under local anesthesia to obtain tissue samples.
The definitive diagnosis of cancer or benign condition is made by the pathologist. In very early breast cancers, the pathologist may need larger samples to state whether the cancer is locally invasive or is in situ meaning that the tumor is still confined to the lining of the milk duct and glands. On those occasions, conventional surgery is necessary.
 Sentinel node biopsy offers a less invasive method to determine whether breast cancer has metastasized.
 The sentinel nodes are the first 1-3 lymph nodes in the lymph chain that drain the breast.
 This tends to be a route that spreading cancer cells take. Sentinel node biopsy proposes that if cancer were to spread,
 it would have to pass through them.
 The "sentinel" node(s), defined as the first node in the lymphatic basin to receive lymphatic flow, is identified and removed in order to prove the presence or absence of metastases to the remainder of the axilla.
 The technique involves the injection of a tracer substance, either a dye or a radio-labeled isotope given at the site of the primary tumor in the breast, prior to its removal or, if the tumor has already been removed, at the biopsy site.
 One to two hours after the injection and prior to surgery, a gamma probe is used to detect areas of increased activity in the axilla, indicating the "sentinel" node where the radioactive tracer has accumulated.
 This area is then marked on the skin, local anesthesia and intravenous sedation are given and a small (1-2 inch) incision is made.
 One or two nodes are then removed for examination by a pathologist.
 Because only a few nodes are taken, pathologists have been able to not only examine multiple sections of the excised nodes, but also do special tests to assure the identification of "micro" metastases (early cancer spread).
 The success rate of the tracer test in finding sentinel node(s) is approximately 95% and the accuracy of the sentinel node(s) to correctly diagnose the spread is also 95%
American Cancer Society Recommendations for Early Breast Cancer Detection
 Women age 40 and older should have a screening mammogram every year.
 Between the ages of 20 and 39, women should have a clinical breast examination by a health professional every 3 years. After age 40, women should have a breast exam by a health professional every year.
 Women age 20 or older should perform a breast self-examination (BSE) every month. By doing the exam regularly, you get to know how your breasts normally feel and you can more readily detect any signs or symptoms.
 If a change occurs, such as development of a lump or swelling, skin irritation or dimpling, nipple pain or retraction (turning inward), redness or scaliness of the nipple or breast skin, or a discharge other than breast milk, you should see your health care provider as soon as possible for evaluation. However, remember that most of the time, these breast changes are not cancer.
 Although there are some features of a mass that suggest whether it is likely to be benign or cancerous, women examining their own breasts should discuss any new lump with their health care professionals.
 Experienced health care professionals can examine the breast and determine whether the changes you have noticed are probably benign or whether there is a possibility they may be due to a breast cancer.
 They can determine when additional tests are appropriate to rule out a cancer and when follow-up exams are the best strategy.
 If there is any suspicion of cancer, a biopsy will be done.
 The American Cancer Society believes the use of mammography, clinical breast examination, and breast self-examination, according to the recommendations outlined above, offers women the best opportunity for reducing the breast cancer death rate through early detection.
 This combined approach is clearly better than any one examination.
 Without question, breast physical examination without mammography would miss the opportunity to detect many breast cancers that are too small for a woman or her doctor to feel but can be seen on mammograms.
 Although mammography is the most sensitive screening method, a small percentage of breast cancers do not show up on mammograms but can be felt by a woman or her doctors.
|